A study published in Nature Microbiology now shows for the first time that Candida auris uses a CO₂-based metabolic strategy to survive in the nutrient-poor conditions of the skin and to better tolerate antifungal therapies – especially amphotericin B (AMB).24. Dezember 2025
News Neura Health Raises $11.4M to Expand Virtual Neurology ClinicHealthradar30. September 2025 What You Should Know: – Neura Health, a virtual neurology clinic raises $11.4M in Series A funding round, bringing the…
